Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare this read-only, idempotent, and non-destructive, and the description adds substantial behavioral context: it fans out across sources in parallel, uses sources_used/sources_failed to indicate real absence of data, returns empty sections for companies with no matching data, and falls back gracefully for private companies. It also explains that missing FDA-listed biologics is expected for small-molecule drug companies, not a bug.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single dense paragraph with many semicolon-separated clauses, and while it is front-loaded with trigger examples and a usage preference, the structure makes it harder to parse than necessary. It contains valuable information throughout, but the redundancy around accepted input shapes and the long parenthetical source list could be organized more cleanly.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema present, the description carries the burden of explaining return behavior, and it does so thoroughly: it enumerates returned fields, describes sources_used/sources_failed, explains empty sections, covers input resolution for names, and defines failure semantics for private companies. It is complete enough for an agent to call the tool correctly and interpret the response.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already fully describes both parameters at 100% coverage, so the baseline is 3. The description adds value by giving concrete examples ("AAPL", "0000320193", "Moderna"), clarifying that type accepts company or ticker interchangeably, and noting the resolved_from/resolved_to behavior when a name is provided. This goes slightly beyond the schema but largely reinforces it.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose: producing a full cross-source profile of a US public company in one parallel call. It names specific sources, output categories, and input forms, and it distinguishes itself from cheaper single-source lookups by explicitly saying it should be preferred when a holistic view is requested.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says when to use this tool: when the user asks for a holistic view, and it instructs the agent to prefer it over chaining single-pack SEC/XBRL/news lookups. It also covers boundary cases such as private companies returning resolved:false and notes rather than a bare failure, which helps the agent know how to interpret results.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Many tools overlap in purpose, such as multiple query tools (ask_pipeworx, ask_pipeworx_grounded, deep_research) and multiple prediction market analysis tools (bet_research, polymarket_arbitrage, polymarket_edges). An agent would struggle to select the appropriate tool due to ambiguous distinctions.

Naming Consistency3/5

Tool names are a mix of styles: some follow verb_noun (ask_pipeworx, forget), others use noun_verb (ecfs_docket_filings), and many are short or compound (bet_research, entity_profile). While the ecfs- prefix tools are consistent, the overall set lacks a uniform pattern.

Tool Count2/5

With 35 tools, the count is excessive for a server named after FCC ECFS, as only 4 tools are directly relevant to that domain. The inclusion of many general-purpose data tools makes the set feel bloated and misaligned with the server's apparent scope.

Completeness3/5

For the FCC ECFS domain, the tool set is incomplete (only 4 tools, lacking submission or deletion capabilities). However, as a general-purpose data query server, it covers many sources (SEC, FDA, patents, etc.). The name mismatch hurts the perceived completeness.